Multidisciplinary intensive lifestyle intervention improves markers of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes and obesity

MedSynapse, Connecting doctors globally. Community of Doctors Are you ready to discover a potential breakthrough in the treatment of non-alcoholic fatty liver disease (NAFLD)? This latest study evaluating the hepatic steatosis index (HSI) levels, the study revealed promising insights into the potential benefits of ILI as a treatment option for NAFLD. This could be a significant step forward in the fight against NAFLD, a condition that affects millions of people worldwide. Stay tuned for more exciting updates on this groundbreaking research! Dr. Kishore Yadav 🕐 3 Mins Read Read More This email is intended for Dr. Renukaprasad A R Unsubscribe / Change your email preferences. © 2023 MedSynapse, USA, Singapore, India, Dubai